Aims and Scope
American Journal of Hematology is an academic journal devoted to the coverage of blood diseases. It has been published since 1976.
Key Metrics
13.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
10 - 15
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
121
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.88
5-Year SI
5-year SI
- 0.91 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Hematology
SJR
- Q1 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2.9
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
39%
4 to 6 months
53%
7 to 9 months
7%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Lymphoma
- Hemoglobin
- Overall survival
- Extracellular vesicles
- Lymphoblastic Leukemia
- Immune thrombocytopenia
- Allele
- Progression-free survival
- Hematopoietic stem cell transplantation
- Dexamethasone
- Bone marrow
- Anemia
- Lenalidomide
- Cancer
- Antibody response
- Acute failure
- Cancer research
- Aspirin
- Methotrexate
- Confocal microscopy
Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in American Journal of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Title not available
- 1 Dec 24
- American Journal of Hematology
-
Full paper
Mini‐consolidations or intermediate‐dose cytarabine for the post‐remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries
- 18 Nov 24
- American Journal of Hematology
-
Full paper
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.
- 16 Nov 24
- American journal of hematology
-
Full paper
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.
- 16 Nov 24
- American journal of hematology
-
Full paper
Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis.
- 16 Nov 24
- American journal of hematology
-
Full paper
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.
- 16 Nov 24
- American journal of hematology
Scite analysis
Powered by scite_
13k articles received 208.7k citations see all
- 9,211 Supporting
- 191,619 Mentioning
- 1,739 Contrasting
Editorial notices
- 2 Retractions
- 1 Withdrawals
- 16 Corrections
- 55 Errata
- 0 Expression of Concern
FAQs
How long has American Journal of Hematology been actively publishing?
American Journal of Hematology has been in operation since 1976 till date.
What is the publishing frequency of American Journal of Hematology ?
American Journal of Hematology published with a Monthly frequency.
How many articles did American Journal of Hematology publish last years ?
In 2023, American Journal of Hematology published 392 articles.
What is the eISSN & pISSN for American Journal of Hematology ?
For American Journal of Hematology,eISSN is 1096-8652 and pISSN is0361-8609.
What is Citescore for American Journal of Hematology ?
Citescore for American Journal of Hematology is 13.4.
What is H index for American Journal of Hematology ?
H index for American Journal of Hematology is 121.
What is SNIP score for American Journal of Hematology ?
SNIP score for American Journal of Hematology is 2.9.
What is the SJR for American Journal of Hematology ?
SJR for American Journal of Hematology is Q1.
Who is the publisher of American Journal of Hematology ?
WILEY is the publisher of American Journal of Hematology.